The treatment of AIDS-related cancers

Lancet Oncology

Volumn 4, Issue 9, 2003, Pages 576-581

  Levine, Alexandra M ^a   Hancock, Barry W ^b   MacPhail, Patrick ^c   Ruff, Paul ^c   Ashcroft, Richard E ^d  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b WESTON PARK HOSPITAL   (United Kingdom)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; BLEOMYCIN; CHLORAMBUCIL; CIDOFOVIR; COL 9; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FOSCARNET; GANCICLOVIR; INDINAVIR; LAMIVUDINE; LIQUID NITROGEN; PACLITAXEL; PEGINTERFERON; PREDNISOLONE; PREDNISONE; PROCARBAZINE; PROTEINASE INHIBITOR; STAVUDINE; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; ZIDOVUDINE; ANTIVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; ARTICLE; BLOOD TOXICITY; BONE MARROW TOXICITY; CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CAUSE OF DEATH; CLINICAL TRIAL; COST; CRYOTHERAPY; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; DRUG RESPONSE; DRUG SAFETY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; KAPOSI SARCOMA; LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; SOUTH AFRICA; TUMOR IMMUNITY; VIRUS TRANSMISSION; B CELL LYMPHOMA; FEMALE; NONHODGKIN LYMPHOMA; REVIEW; UTERINE CERVIX TUMOR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; FEMALE; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; SARCOMA, KAPOSI; UTERINE CERVICAL NEOPLASMS;

EID: 0141765900     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(03)01198-7     Document Type: Note

References (57)

1. Palella F.J.Jr Delaney K.M. Moorman A.C. et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection New Engl J Med 338 1998 853-860
2. Ledergerber B. Egger M. Erard V. et al. AIDS related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study JAMA 282 1999 2220-2226
3. International Collaboration on HIV and Cancer Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus infected adults J Natl Cancer Inst 92 2000 1823-1830
4. Chang Y. Cesarman E. Pessin M.S. et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kpaosi's sarcoma Science 266 1994 1865-1869
5. Grulich A.E. Kaldor J.M. Hendry O. et al. Risk of Kaposi's sarcoma and oro-anal sexual contact Am J Epidemiol 145 1997 673-679
6. Tavio M. Nasti G. Spina M. et al. Highly active anti-retroviral therapy in HIV related Kaposi's sarcoma Ann Oncol 9 1998 923
7. Bower M. Fox P. Fife K. et al. Highly active anti-retroviral therapy prolongs time to treatment failure in Kaposi's sarcoma AIDS 13 1999 2105-2111
8. Sgadari C. Barillari G. Toschi E. et al. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi's sarcoma Nat Med 8 2002 225-232
9. Walmsley S. Northfelt D.W. Melosky B. et al. Treatment of AIDS related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic) gel J AIDS 22 1999 235-246
10. Kirova Y.M. Belembaogo E. Frikha H. et al. Radiotherapy in the management of epidemic Kaposi's sarcoma: a retrospective study of 643 cases Radiother Oncol 46 1998 19-22
11. Chak L.Y. Gill P.S. Levine A.M. et al. Radiation therapy for acquired immunodeficiency syndrome related KS J Clin Oncol 6 1988 863-867
12. Gill P.S. Rarick M.U. McCutchan J.A. et al. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial Am J Med 19 1991 427-433
13. Gill P.S. Wernz J. Scadden D.T. et al. Randomized phase III trial of liposomal daunorubicin (DaunoXome) versus doxorubicin, bleomycin, vincristine (ABV) in AIDS related Kaposi's sarcoma J Clin Oncol 14 1996 2353-2364
14. Northfelt D.W. Dezube B. Thommes J.A. et al. Pegylated liposomal doxorubicin versus doxorubicin, bleomycin and vincristine in the treatment of AIDS related Kaposi's sarcoma: results of a randomized phase III clinical trial J Clin Oncol 16 1998 2445-2451
15. Welles L. Saville W. Lietzau J. et al. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma J Clin Oncol 16 1998 1112-1121
16. Krown S.E. The role of interferon in the therapy of epidemic Kaposi's sarcoma Semin Oncol 14 1987 27-33
17. Kedes D.H. Ganem D. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs J Clin Invest 99 1997 2082-2086
18. Little RF, Merced-Galindez F, Humphrey R, et al. A clinical trial of cidofovir in patients with Kaposi's sarcoma. Proceedings of the 5th International AIDS Malignancy Conference, Bethesda, MD, USA.
19. Mocroft A. Katama C. Johnson A.M. et al. AIDS across Europe, 1994-1998: the EuroSIDA study Lancet 356 2000 291-296
20. Levine A.M. AIDS related lymphoma (review) Blood 80 1992 8-20
21. Kaplan L.D. Straus D.J. Testa M.A. et al. Randomized trial of standard-dose versus low dose mBACOD chemotherapy for HIV-associated non-Hodgkin's lymphoma N Engl J Med 336 1997 1641-1648
22. Ratner L. Lee J. Tang S. et al. Chemotherapy for HIV associated non-Hodgkin's lymphoma in combination with highly active anti-retroviral therapy J Clin Oncol 19 2001 2171-2178
23. Gill P.S. Rarick M.U. Brynes R.L. et al. Azidothymidine and bone marrow failure in AIDS Ann Intern Med 107 1987 502-505
24. Antinori A. Cingolani A. Alba L. et al. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy AIDS 15 2001 1483-1491
25. Sparano JA, Lee S, Chen MG, et al. Infusional cyclophosphamide, doxorubicin and etoposide in HIV associated non-Hodgkin's lymphoma: long term follow-up of ECOG trial E 1494. Proceedings of the 6th International Conference on Malignancies in AIDS and Other Immunodeficiencies, Bethesda, MD, USA, 2002.
26. Little R.F. Pittaluga S. Grant N. et al. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumour biology Blood 101 2003 4653-4659
27. Canellos G.P. DeVita V.T. Arseneau J.C. et al. Second malignancies complicating Hodgkin's disease in remission Lancet 1 1975 947-949
28. Valagussa P. Santoro A. Fossati-Bellani F. et al. Second acute leukaemia and other malignancies following treatment for Hodgkin's disease J Clin Oncol 4 1986 830-837
29. Swerdlow A.J. Douglas A.J. Vaughan Hudson G. et al. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2,846 patients in the British National Lymphoma Investigation BMJ 304 1992 1137-1143
30. Tucker M.A. Coleman C.N. Cox R.S. et al. Risk of second cancers after treatment for Hodgkin's disease New Eng J Med 318 1988 76-81
31. Boivin J.F. Hutchinson G.B. Auber A.G. et al. Incidence of second cancers in patients treated for Hodgkin's disease J Natl Cancer Inst 87 1995 732-741
32. van Leeuwen F.E. Klokman W.J. Stovall M. et al. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease J Natl Cancer Inst 87 1995 1530-1537
33. Hancock S.L. Tucker M.A. Hoppe R.T. Breast cancer after treatment of Hodgkin's disease J Natl Cancer Inst 85 1993 25-31
34. Swerdlow A.J. Barber J.A. Vaughan Hudson G. et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment J Clin Oncol 18 2000 498-509
35. Metayer C. Lynch C.F. Clarke E.A. et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence J Clin Oncol 18 2000 2435-2443
36. Travis L.B. Curtis R.E. Boice J.D. et al. Second cancers following non-Hodgkin's lymphoma Cancer 67 1991 2002-2009
37. Henry-Amar M. Long-term problems in malignant lymphoma In: Hancock B.W. Selby P.J. MacLennan K. Armitage J.O. (Eds.), Malignant lymphoma 2000 421-436 Arnold London
38. Okines A.F.C. Radstone C.R. Thomson C. et al. Subsequent primary cancers after treatment for Hodgkin's disease and non-Hodgkin's lymphoma Br J Cancer 86 suppl 1 2002 S41
39. Perinatal HIV Research Unit. http://www.hivsa.com , accessed Aug 2003.
40. Reproductive Health Research Unit. http://www.rhru.co.za , accessed Aug 2003
41. Department of Health. Recommendations for the prevention and treatment of opportunistic and HIV related diseases in adults. http://196.36.153.56/doh/aids/docs/adult.html , accessed Aug 2003.
42. Thomas J.O. Acquired immunodeficiency syndrome-associated cancers in sub-Saharan Africa Semin Oncol 28 2001 198-206
43. Laubenstein L.J. Krigel R.L. Odajnyk C.M. et al. Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine J Clin Oncol 2 1984 1115-1120
44. Mahomed A.G. Murray J. Klempman S. et al. Pneumocystis carinii pneumonia in HIV infected patients from South Africa East Afr Med J 76 1999 80-84
45. Human Sciences Research Council. Nelson Mandela/HSRC Study of HIV/AIDS 2002. http://www.hsrcpublishers.co.za/index.html?hiv.html~content, accessed Aug 2003.
46. IDASA Budget Information Service. Idasa statement on budget 2003. http://www.idasact.org.za/bis/docs/IdasaStatementOnBudget2003-270203.html , accessed Aug 2003.
47. Roland M.E. Stock P.G. Review of solid organ transplantation in HIV-infected patients Transplantation 75 2003 425-429
48. Englert Y. van Vooren J.-P. Place I. et al. ART in HIV infected couples: has the time come for a change in attitude? Hum Reprod 16 2001 1309-1315
49. Cook R.J. Dickens B.M. Human rights and HIV-positive women Int J Gynaecol Obstet 77 2002 55-63
50. World Health Organisation. Essential Medicines: WHO Model List (revised April 2002). Core List. (12th edn) http://www.who.int/medicines/ organization/par/edl/eml.shtml accessed Aug 2003.
51. World Health Organisation. Essential Medicines: WHO Model List (revised April 2002). Complementary List. (12th edn) http://www.who.int/ medicines/organization/par/edl/eml.shtml, accessed Aug 2003.
52. Barnett T. Whiteside A. AIDS in the twenty-first century: disease and globalization 2002 Palgrave MacMillan Basingstoke
53. Daniels N. Justice, health and health care Am J Bioeth 1 2001 2-16
54. Ubel P.A. Pricing life: why it's time for health care rationing 2000 MIT Press Cambridge
55. Emanuel E.J. Emanuel L.L. The economics of dying: the illusion of cost-savings at the end of life N Engl J Med 330 1995 540-544
56. Taylor B. HIV, stigma, and health: Integration of theoretical concepts and the lived experience of individuals J Adv Nurs 35 2001 792-798
57. De Beaufort I. Individual responsibility for health In Bennett R. Erin C.A. (Eds.), HIV and AIDS: Testing, screening and confidentiality 1999 107-124 Oxford University Press Oxford